Understanding the dynamics of the EGFR, Src and Stat3 molecular interactions in pancreatic cancer would provide basis to design novel effective multiple-targeted therapy approaches for pancreatic cancer. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.